SCHEMBL30924197

SCHEMBL30924197

C#Cc1cccc(OCCOC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.46
▸ ILK Q13418 5/20 0.46
▸ ERBB2 P04626 3/20 0.46
▸ GAK O14976 2/20 0.46
▸ SYK P43405 2/20 0.46
▸ PLK4 O00444 1/20 0.46
▸ CIT O14578 1/20 0.46
▸ AURKA O14965 1/20 0.46
▸ EPHB6 O15197 1/20 0.46
▸ SLC22A1 O15245 1/20 0.46
▸ DAPK3 O43293 1/20 0.46
▸ RIPK2 O43353 1/20 0.46
▸ BUB1 O43683 1/20 0.46
▸ KDM1A O60341 1/20 0.46
▸ JAK2 O60674 1/20 0.46
▸ RPS6KA4 O75676 1/20 0.46
▸ STK17B O94768 1/20 0.46
▸ STK10 O94804 1/20 0.46
▸ SLCO2B1 O94956 1/20 0.46
▸ ABCB11 O95342 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2971332 1.00 EGFR (0.46) EGFRILKERBB2GAKSYK
SCHEMBL6089720 0.89 EGFR (0.41) EGFRILKERBB2GAKSYK
SCHEMBL6358005 0.84 FFAR1 (0.37) EGFRILKERBB2GAKSYK
SCHEMBL1772406 0.83 EGFR (0.45) EGFRILKLMNACYP3A4MAPK1
SCHEMBL29996269 0.83 TBXAS1 (0.52) MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL2908379 0.83 TBXAS1 (0.52) MAPK1CYP1A2CYP2D6CYP2C19
SCHEMBL16957855 0.83 MAPK1 (0.43) SYKLMNAMAPK1CYP1A2CYP2D6
SCHEMBL15723552 0.81 MAPK1 (0.58) SYKLMNACYP3A4MAPK1CYP1A2
SCHEMBL14698298 0.81 KCNH2 (0.41) EGFRALDH1A1
SCHEMBL2935432 0.81 FABP7 (0.40) EGFRERBB2LMNAMAPK1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117769548-A Aromatic acetylene derivative and preparation method and application thereof 浙江海正药业股份有限公司 2024-03-26 — — CN disclosed
Send feedback